drugset / Trial / NCT03862404
Intrapleural Bupivacaine for Ipsilateral Shoulder Pain After Thoracotomy
Phase 4
Completed
42 enrolled
McGill University Health Centre/Research Institute of the McGill University Health Centre
RandomizedSingle-groupDouble-blindTreatment
Summary
While thoracic epidural could control incisional pain after thoracotomy, an excruciating ipsilateral shoulder pain happens post thoracotomy and could affect up to 85% of thoracotomy patients. It is often difficult to manage and relatively resistant to opioids. The investigators postulate that in the presence of a functioning thoracic epidural, intrapleural bupivacaine administered through the chest tube could be effective in reducing post thoracotomy ipsilateral shoulder pain.
Timeline
- Start
- 2017-07-01
- Primary completion
- 2019-02-15
- Completion
- 2019-02-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 0.25 % | Other |
| Subject | Epinephrine | Other / unclassified | 5 ug/ml | Other |
Indications
No indication recorded.